Key result
High remnant cholesterol linked to ~48% lower 30-day mortality in critically ill HF patients.
Why the study?
Remnant cholesterol is a significant cardiovascular risk factor, but its prognostic value in critically ill patients with heart failure remains inadequately characterized.
Are higher remnant cholesterol levels associated with reduced mortality in critically ill patients with heart failure?
Cohort (n=3,750)
Are higher remnant cholesterol levels associated with reduced mortality in critically ill patients with heart failure?
Hazard Ratio: 0.52 (95% CI 0.31–0.87)
In critically ill patients with heart failure, higher remnant cholesterol levels are paradoxically associated with reduced 30-day and 1-year all-cause mortality.
No takes yet. Share an insight, caveat, or question.
Higher remnant cholesterol should not guide therapy in critical HF; hypothesis-generating and requires prospective validation.
Zhang et al. (2026) conducted a cohort in Critically ill patients with heart failure (n=3,750). High remnant cholesterol (≥54.0 mg/dL) vs. Low remnant cholesterol (<22.7 mg/dL) was evaluated on 30-day all-cause mortality (HR 0.52, 95% CI 0.31-0.87). High remnant cholesterol levels were associated with a significant reduction in 30-day all-cause mortality compared to low levels (HR 0.52; 95% CI 0.31-0.87) in critically ill heart failure patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: